GlassScriptPhysician profile
Robert M Sherman
NPI 1225082258
$603.44
in general payments reported to CMS, 2019-2025
8 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.10 · 2022: $174 · 2023: $155 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $152.28 | 2023-2025 | Izervay |
| Mallinckrodt Hospital Products INC. | $122.92 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $122.08 | 2025 | Syfovre |
| Antares Pharma, INC. | $88.15 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Lkc Technologies, INC. | $58.21 | 2025 | |
| Genentech USA, INC. | $27.01 | 2025 | Vabysmo |
| Oyster Point Pharma, INC. | $18.33 | 2022 | |
| Rxsight INC | $14.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.